505 Comparison of profile and utility measures of health-related quality of life in pediatric Hodgkin lymphoma
Objectives/Goals: Our aim is to compare scores collected from a health utilities measure (Health Utility Index, HUI) to those collected from a profile measure (Child Health Ratings Inventories, CHRIs- Global) among youth with newly diagnosed, high-risk classic Hodgkin lymphoma. Methods/Study Populat...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2025-04-01
|
| Series: | Journal of Clinical and Translational Science |
| Online Access: | https://www.cambridge.org/core/product/identifier/S2059866124010896/type/journal_article |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849393783362289664 |
|---|---|
| author | Brian Felter Angie Mae Rodday Susan K. Parsons |
| author_facet | Brian Felter Angie Mae Rodday Susan K. Parsons |
| author_sort | Brian Felter |
| collection | DOAJ |
| description | Objectives/Goals: Our aim is to compare scores collected from a health utilities measure (Health Utility Index, HUI) to those collected from a profile measure (Child Health Ratings Inventories, CHRIs- Global) among youth with newly diagnosed, high-risk classic Hodgkin lymphoma. Methods/Study Population: We will analyze existing data collected during the Children’s Oncology Group AHOD 1331 trial, which was a phase 3 clinical trial comparing the efficacy of adding brentuximab vedotin to standard-of-care treatment with multiagent chemotherapy in children and adolescents with high-risk Hodgkin lymphoma. The study also had a prespecified patient-reported outcomes (PRO) secondary aim, which involved recruiting a subset of the initial 309 patients aged 11 years or older enrolled in the trial for serial PRO measures taken over the trial period. Health-related quality of life (HRQoL) was assessed by CHRIs, HUI version 2, and HUI version 3 assessments at six planned points throughout treatment. Results/Anticipated Results: The first step of our analysis will be to ascertain agreement in scoring for parent–child dyads for the HUI2, HUI3, and CHRIs scores by comparing mean scores via two-sample t-testing. Bland–Altman plots will be constructed to compare agreement between the scores for HUI2/3 and the CHRIs. Similarly, Spearman’s correlation coefficients will be calculated for CHRIs with HUI2/3 for both parents and children. We hypothesize the CHRIs and HUI scores should roughly correlate with one another, but there may be divergence of correlation because the HUI has greater emphasis on functionality (e.g., sensation, mobility), and the CHRIs further emphasize social and emotional well-being in addition to physical health. Discussion/Significance of Impact: The composite score of the HUI 2/3 has allowed for direct comparison with other global HRQoL measures, providing greater clarity of its performance in different patient populations and clinical settings. The current study will improve understanding of the HUI 2/3 performance in a pediatric cancer population over time. |
| format | Article |
| id | doaj-art-032b1e70a6a34ca3b7da7c47e08702d5 |
| institution | Kabale University |
| issn | 2059-8661 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Cambridge University Press |
| record_format | Article |
| series | Journal of Clinical and Translational Science |
| spelling | doaj-art-032b1e70a6a34ca3b7da7c47e08702d52025-08-20T03:40:18ZengCambridge University PressJournal of Clinical and Translational Science2059-86612025-04-01914814810.1017/cts.2024.1089505 Comparison of profile and utility measures of health-related quality of life in pediatric Hodgkin lymphomaBrian Felter0Angie Mae Rodday1Susan K. Parsons2Tufts University, Clinical & Translational Science Graduate ProgramTufts University, Clinical & Translational Science Graduate ProgramTufts University, Clinical & Translational Science Graduate ProgramObjectives/Goals: Our aim is to compare scores collected from a health utilities measure (Health Utility Index, HUI) to those collected from a profile measure (Child Health Ratings Inventories, CHRIs- Global) among youth with newly diagnosed, high-risk classic Hodgkin lymphoma. Methods/Study Population: We will analyze existing data collected during the Children’s Oncology Group AHOD 1331 trial, which was a phase 3 clinical trial comparing the efficacy of adding brentuximab vedotin to standard-of-care treatment with multiagent chemotherapy in children and adolescents with high-risk Hodgkin lymphoma. The study also had a prespecified patient-reported outcomes (PRO) secondary aim, which involved recruiting a subset of the initial 309 patients aged 11 years or older enrolled in the trial for serial PRO measures taken over the trial period. Health-related quality of life (HRQoL) was assessed by CHRIs, HUI version 2, and HUI version 3 assessments at six planned points throughout treatment. Results/Anticipated Results: The first step of our analysis will be to ascertain agreement in scoring for parent–child dyads for the HUI2, HUI3, and CHRIs scores by comparing mean scores via two-sample t-testing. Bland–Altman plots will be constructed to compare agreement between the scores for HUI2/3 and the CHRIs. Similarly, Spearman’s correlation coefficients will be calculated for CHRIs with HUI2/3 for both parents and children. We hypothesize the CHRIs and HUI scores should roughly correlate with one another, but there may be divergence of correlation because the HUI has greater emphasis on functionality (e.g., sensation, mobility), and the CHRIs further emphasize social and emotional well-being in addition to physical health. Discussion/Significance of Impact: The composite score of the HUI 2/3 has allowed for direct comparison with other global HRQoL measures, providing greater clarity of its performance in different patient populations and clinical settings. The current study will improve understanding of the HUI 2/3 performance in a pediatric cancer population over time.https://www.cambridge.org/core/product/identifier/S2059866124010896/type/journal_article |
| spellingShingle | Brian Felter Angie Mae Rodday Susan K. Parsons 505 Comparison of profile and utility measures of health-related quality of life in pediatric Hodgkin lymphoma Journal of Clinical and Translational Science |
| title | 505 Comparison of profile and utility measures of health-related quality of life in pediatric Hodgkin lymphoma |
| title_full | 505 Comparison of profile and utility measures of health-related quality of life in pediatric Hodgkin lymphoma |
| title_fullStr | 505 Comparison of profile and utility measures of health-related quality of life in pediatric Hodgkin lymphoma |
| title_full_unstemmed | 505 Comparison of profile and utility measures of health-related quality of life in pediatric Hodgkin lymphoma |
| title_short | 505 Comparison of profile and utility measures of health-related quality of life in pediatric Hodgkin lymphoma |
| title_sort | 505 comparison of profile and utility measures of health related quality of life in pediatric hodgkin lymphoma |
| url | https://www.cambridge.org/core/product/identifier/S2059866124010896/type/journal_article |
| work_keys_str_mv | AT brianfelter 505comparisonofprofileandutilitymeasuresofhealthrelatedqualityoflifeinpediatrichodgkinlymphoma AT angiemaerodday 505comparisonofprofileandutilitymeasuresofhealthrelatedqualityoflifeinpediatrichodgkinlymphoma AT susankparsons 505comparisonofprofileandutilitymeasuresofhealthrelatedqualityoflifeinpediatrichodgkinlymphoma |